Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control

被引:18
|
作者
Araz, M [1 ]
Celen, Z
Akdemir, I
Okan, V
机构
[1] Gaziantep Univ, Fac Med, Dept Internal Med, TR-27070 Gaziantep, Turkey
[2] Gaziantep Univ, Fac Med, Dept Nucl Med, Gaziantep, Turkey
[3] Gaziantep Univ, Fac Med, Dept Cardiol, Gaziantep, Turkey
关键词
silent myocardial ischemia; type 2 diabetes mellitus; HbA(1c); retinopathy;
D O I
10.1007/s00592-004-0142-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to investigate the frequency of silent myocardial ischemia in type 2 diabetic patients without any clinical or laboratory findings of myocardial ischemia and to examine the related factors for silent myocardial ischemia. A total of 116 type 2 diabetic patients (82 women) with a disease duration of 5-20 years were included in the study. All patients underwent stress and resting myocardial perfusion single-photon emission computed tomographic (SPECT) study with Tc-99m-MIBI. Coronary angiography was performed in patients with ischemia established at myocardial perfusion SPECT. Ischemia was determined in 18 (15.5%) patients by myocardial perfusion SPECT. Coronary angiography performed in 17 of these patients confirmed coronary stenosis >50% in 11 patients. Thus, the prevalence of silent myocardial ischemia was 9.6%. Significant relations were found between silent myocardial ischemia and male sex, high HbA(1C) level and retinopathy. Type 2 diabetic patients (especially men) with poorly controlled diabetes mellitus or retinopathy should be screened for silent myocardial ischemia.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [21] Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications
    Hemmat El Haddad
    Heba Sedrak
    Mervat Naguib
    Elham Yousief
    Dalia R. Ibrahim
    Rasha M. Abdel Samie
    Ahmed Hamdy
    International Journal of Diabetes in Developing Countries, 2019, 39 : 641 - 646
  • [22] Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications
    El Haddad, Hemmat
    Sedrak, Heba
    Naguib, Mervat
    Yousief, Elham
    Ibrahim, Dalia R.
    Samie, Rasha M. Abdel
    Hamdy, Ahmed
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2019, 39 (04) : 641 - 646
  • [23] In vivo oxidizability of LDL in type 2 diabetic patients in good and poor glycemic control
    Gambino, R
    Uberti, B
    Alemanno, N
    Pisu, E
    Pagano, G
    Cassader, M
    ATHEROSCLEROSIS, 2004, 173 (01) : 103 - 107
  • [24] COMPARISON OF DIETARY PATTERNS OF TYPE 2 DIABETIC PATIENTS WITH GOOD AND POOR GLYCEMIC CONTROL
    Muktabhant, Benja
    Thonguthaisiri, Amornrat
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 539 - 539
  • [25] Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control
    Larsen, J
    Brekke, M
    Sandvik, L
    Arnesen, H
    Hanssen, KF
    Dahl-Jorgensen, K
    DIABETES, 2002, 51 (08) : 2637 - 2641
  • [26] Inflammation markers in the diabetic population: Influence of short-term glycemic control and of silent myocardial ischemia
    Valensi, P
    Cosson, E
    Vaisse, J
    Paries, J
    Gattegno, L
    Attali, JR
    DIABETES, 2004, 53 : A189 - A189
  • [27] Silent myocardial ischemia in patients with diabetes mellitus type 2
    Koshlia, V. I.
    Martynenko, A. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2015, (06) : 88 - 92
  • [28] Myocardial ischemia: a silent epidemic in Type 2 diabetes patients
    Le Feuvre, Claude
    Jacqueminet, Sophie
    Barthelemy, Olivier
    FUTURE CARDIOLOGY, 2011, 7 (02) : 183 - 190
  • [29] Predictive value of silent myocardial ischemia in diabetic patients
    Valensi, P
    Harfouche, B
    Sachs, RN
    Lormeau, B
    Leutenegger, M
    Attali, JR
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 263 - 263
  • [30] Clinical and metabolic predictors of silent myocardial ischemia in type 2 diabetic males
    Mamcarz, A
    Braksator, W
    Kuch, M
    Krol, J
    Chmielewski, M
    Kuch, J
    Leowski, J
    Szczeklik, Z
    Walasik, L
    Taton, J
    23RD CONGRESS OF THE INTERNATIONAL SOCIETY OF INTERNAL MEDICINE, 1996, : 89 - 92